These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36960651)

  • 1. The challenge of dementia prevention trials and the role of quasi-experimental studies.
    Lindhout JE; van Dalen JW; van Gool WA; Richard E
    Alzheimers Dement; 2023 Aug; 19(8):3722-3730. PubMed ID: 36960651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety interventions for the prevention of accidents at work: A systematic review.
    Dyreborg J; Lipscomb HJ; Nielsen K; Törner M; Rasmussen K; Frydendall KB; Bay H; Gensby U; Bengtsen E; Guldenmund F; Kines P
    Campbell Syst Rev; 2022 Jun; 18(2):e1234. PubMed ID: 36911341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI).
    Richard E; Andrieu S; Solomon A; Mangialasche F; Ahtiluoto S; Moll van Charante EP; Coley N; Fratiglioni L; Neely AS; Vellas B; van Gool WA; Kivipelto M
    J Neurol Sci; 2012 Nov; 322(1-2):64-70. PubMed ID: 22818266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quasi-experimental study designs series-paper 10: synthesizing evidence for effects collected from quasi-experimental studies presents surmountable challenges.
    Becker BJ; Aloe AM; Duvendack M; Stanley TD; Valentine JC; Fretheim A; Tugwell P
    J Clin Epidemiol; 2017 Sep; 89():84-91. PubMed ID: 28365308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quasi experimental evaluation of public health interventions (author's transl)].
    Patrick DL
    Rev Epidemiol Sante Publique; 1981; 29(3):245-53. PubMed ID: 7302309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
    McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
    Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quasi-experimental study designs series-paper 2: complementary approaches to advancing global health knowledge.
    Geldsetzer P; Fawzi W
    J Clin Epidemiol; 2017 Sep; 89():12-16. PubMed ID: 28365307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational Studies.
    Hess DR
    Respir Care; 2023 Nov; 68(11):1585-1597. PubMed ID: 37339891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for preventing delirium in older people in institutional long-term care.
    Woodhouse R; Burton JK; Rana N; Pang YL; Lister JE; Siddiqi N
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD009537. PubMed ID: 31012953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based medicine-When observational studies are better than randomized controlled trials.
    Bosdriesz JR; Stel VS; van Diepen M; Meuleman Y; Dekker FW; Zoccali C; Jager KJ
    Nephrology (Carlton); 2020 Oct; 25(10):737-743. PubMed ID: 32542836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental laboratory models as tools for understanding modifiable dementia risk.
    Sinclair D; Canty AJ; Ziebell JM; Woodhouse A; Collins JM; Perry S; Roccati E; Kuruvilla M; Leung J; Atkinson R; Vickers JC; Cook AL; King AE
    Alzheimers Dement; 2024 Jun; 20(6):4260-4289. PubMed ID: 38687209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational designs in clinical multiple sclerosis research: Particulars, practices and potentialities.
    Jongen PJ
    Mult Scler Relat Disord; 2019 Oct; 35():142-149. PubMed ID: 31394404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying causal effects from observed data using quasi-intervention.
    Yang J; Wan Y; Ni Q; Zuo J; Wang J; Zhang X; Zhou L
    BMC Med Inform Decis Mak; 2022 Dec; 22(1):337. PubMed ID: 36544217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Modifiable Are Modifiable Dementia Risk Factors? A Framework for Considering the Modifiability of Dementia Risk Factors.
    Bransby L; Rosenich E; Maruff P; Lim YY
    J Prev Alzheimers Dis; 2024; 11(1):22-37. PubMed ID: 38230714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quasi-experimental research designs.
    Behi R; Nolan M
    Br J Nurs; 1996 Sep 26-Oct 9; 5(17):1079-81. PubMed ID: 8918770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.
    Rouch L; Cestac P; Hanon O; Cool C; Helmer C; Bouhanick B; Chamontin B; Dartigues JF; Vellas B; Andrieu S
    CNS Drugs; 2015 Feb; 29(2):113-30. PubMed ID: 25700645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidomain trials to prevent dementia: addressing methodological challenges.
    Montero-Odasso M; Zou GY; Kamkar N; Feldman HH; Belleville S; Chertkow H; Nygaard HB; Son S; Speechley M
    Alzheimers Res Ther; 2022 Jul; 14(1):94. PubMed ID: 35820915
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.